
Page#1
Item 8. Financial statements and supplementary data
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
At August 31, 2018 and 2017
(in millions, except shares and per share amounts)
2018 2017
Assets
Current assets:
Cash and cash equivalents $ 785 $ 3,301
Accounts receivable, net 6,573 6,528
Inventories 9,565 8,899
Other current assets 923 1,025
Total current assets 17,846 19,753
Non-current assets:
Property, plant and equipment, net 13,911 13,642
Goodwill 16,914 15,632
Intangible assets, net 11,783 10,156
Equity method investments (see note 5) 6,610 6,320
Other non-current assets 1,060 506
Total non-current assets 50,278 46,256
Total assets $ 68,124 $66,009
Liabilities and equity
Current liabilities:
Short-term debt $ 1,966 $ 251
Trade accounts payable (see note 17) 13,566 12,494
Accrued expenses and other liabilities 5,862 5,473
Income taxes 273 329
Total current liabilities 21,667 18,547
Non-current liabilities:
Long-term debt 12,431 12,684
Deferred income taxes 1,815 2,281
Other non-current liabilities 5,522 4,223
Total non-current liabilities 19,768 19,188
Commitments and contingencies (see note 10)
Equity:
Preferred stock $.01 par value; authorized 32 million shares, none issued — —
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at August 31, 2018
and 2017 12 12
Paid-in capital 10,493 10,339
Retained earnings 33,551 30,137
Accumulated other comprehensive loss (3,002) (3,051)
Treasury stock, at cost; 220,380,200 shares at August 31, 2018 and 148,664,548 at August 31, 2017 (15,047) (9,971)
Total Walgreens Boots Alliance, Inc. shareholders’ equity 26,007 27,466
Noncontrolling interests 682 808
Total equity 26,689 28,274
Total liabilities and equity $ 68,124 $66,009
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 67 -
Page#2
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
For the years ended August 31, 2018, 2017 and 2016
(in millions, except per share amounts)
2018 2017 2016
Sales $ 131,537 $118,214 $117,351
Cost of sales 100,745 89,052 87,477
Gross profit 30,792 29,162 29,874
Selling, general and administrative expenses 24,569 23,740 23,910
Equity earnings in AmerisourceBergen 191 135 37
Operating income 6,414 5,557 6,001
Other income (expense) 177 (11) (261)
Earnings before interest and income tax provision 6,591 5,546 5,740
Interest expense, net 616 693 596
Earnings before income tax provision 5,975 4,853 5,144
Income tax provision 998 760 997
Post tax earnings from other equity method investments 54 8 44
Net earnings 5,031 4,101 4,191
Net earnings attributable to noncontrolling interests 7 23 18
Net earnings attributable to Walgreens Boots Alliance, Inc. $ 5,024 $ 4,078 $ 4,173
Net earnings per common share:
Basic $ 5.07 $ 3.80 $ 3.85
Diluted $ 5.05 $ 3.78 $ 3.82
Dividends declared per share $ 1.640 $ 1.525 $ 1.455
Weighted average common shares outstanding:
Basic 991.0 1,073.5 1,083.1
Diluted 995.0 1,078.5 1,091.1
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 69 -
Page#3
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the years ended August 31, 2018, 2017 and 2016
(in millions)
2018 2017 2016
Cash flows from operating activities:
Net earnings $ 5,031 $ 4,101 $ 4,191
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization 1,770 1,654 1,718
Change in fair value of warrants and related amortization — — 516
Gain on previously held equity interest (337) — —
Deferred income taxes (322) (434) (442)
Stock compensation expense 130 91 115
Equity earnings from equity method investments (244) (143) (81)
Other 296 364 148
Changes in operating assets and liabilities:
Accounts receivable, net (391) (153) 115
Inventories 331 98 (644)
Other current assets (22) — 66
Trade accounts payable 1,323 1,690 1,572
Accrued expenses and other liabilities 281 (128) 313
Income taxes 694 44 202
Other non-current assets and liabilities (275) 67 58
Net cash provided by operating activities 8,265 7,251 7,847
Cash flows from investing activities:
Additions to property, plant and equipment (1,367) (1,351) (1,325)
Proceeds from sale leaseback transactions — 444 60
Proceeds from sale of businesses — — 74
Proceeds from sale of other assets 655 59 155
Business, investment and asset acquisitions, net of cash acquired (4,793) (88) (126)
Investment in AmerisourceBergen — — (2,360)
Other 4 93 5
Net cash used for investing activities (5,501) (843) (3,517)
Cash flows from financing activities:
Net change in short-term debt with maturities of 3 months or less 586 33 29
Proceeds from debt 5,900 — 5,991
Payments of debt (4,890) (6,196) (791)
Stock purchases (5,228) (5,220) (1,152)
Proceeds related to employee stock plans 174 217 235
Cash dividends paid (1,739) (1,723) (1,563)
Other (98) (45) (143)
Net cash (used for) provided by financing activities (5,295) (12,934) 2,606
Effect of exchange rate changes on cash and cash equivalents 15 20 (129)
Changes in cash and cash equivalents:
Net (decrease) increase in cash and cash equivalents (2,516) (6,506) 6,807
Cash and cash equivalents at beginning of period 3,301 9,807 3,000
Cash and cash equivalents at end of period $ 785 $ 3,301 $ 9,807
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 71 -